The Employees’ State Insurance Corporation (ESIC) on May 30, 2024, issued the notification regarding the Addition and deletion of drugs in the existing drug schedule of DGESIC Rate Contract No. 149,150,151,152 and 153.
ESI Institutions may give recommendations regarding the addition and deletion of drugs as per the instructions given below:
• For recommendations regarding the addition of drugs to the existing drug schedule, the Dean/Medical Superintendent/DIMS of the respective ESI Institution to ensure that
o Recommendations should be sought from Heads of respective Departments for generic drugs duly certifying that:
a. There is no such generic drug available in the existing drug schedule of DG-ESIC Central Rate Contracts.
b. There is no other similar generic substitute available for this drug in the existing DG-ESIC Central Rate Contracts.
o The Drug recommended should mandatorily be supported by data of local purchases of that particular drug during the last one year duly signed by the Medical Store In charge and counter signed/approved by the Dean/Medical Superintendent/DIMS of the respective ESI Institution
• The Institution Head (Dean/MS/DIMS) will give final recommendations for a consolidated list of all drugs received from all departments for addition and deletion of drugs separately after due verification of recommendations of the Heads of respective Departments and Medical Store local purchase data. The recommendations should be submitted before June 10, 2024, through email at [email protected]. The data of addition and deletion of items should be submitted in PDF and excel both without changing the format as enclosed.
[Notification No. U-25/12/165to169/2024-Medical-V (E-754406)]
